Effect of aqueous extract of Aegle marmelos unripe fruit on inflammatory bowel disease

Indian Journal of Pharmacology

Volumn 44, Issue 5, 2012, Pages 614-618

  Behera, Jayanti ^a   Mohanty, Bisweswar ^b   Ramani, Y ^a   Rath, Bandana ^a   Pradhan, Supriya ^a  

^a MKCG MEDICAL COLLEGE   (India)

^b Sun Pharma ^*  (India)

Author keywords

Aegle marmelos (bael); aqueous extract; inflammatory bowel disease

Indexed keywords

ACETIC ACID; AEGLE MARMELOS EXTRACT; GASTROINTESTINAL AGENT; INDOMETACIN; MALONALDEHYDE; PLANT EXTRACT; PREDNISOLONE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE RESPONSE; ENTERITIS; ENZYME ACTIVITY; FEMALE; FRUIT; HISTOPATHOLOGY; MALE; MAST CELL; MAST CELL DEGRANULATION; MESENTERY; MICROSCOPY; NONHUMAN; PATHOGENESIS; PHYTOCHEMISTRY; RAT; THERAPY EFFECT; ULCERATIVE COLITIS;

AEGLE MARMELOS (BAEL); AQUEOUS EXTRACT; INFLAMMATORY BOWEL DISEASE;

AEGLE; ANIMALS; FEMALE; FRUIT; INFLAMMATORY BOWEL DISEASES; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; TREATMENT OUTCOME; WATER;

EID: 84866242705     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.100389     Document Type: Article

References (44)

1. Sellin JH, Pasricha PJ. Pharmacotherapy of infl ammatory bowel disease. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 11th ed. McGraw-Hill Publications,NewYork; 2006. p. 1009.
2. Bickson SJ. Treatment of chronic disease at the turn of the century. N Engl J Med 1998;339:401-2.
3. Hana Strul MD, Nadir Arber MD. Infl ammatory bowel disease, ulcerative colitis, Crohn's disease, pathophysiology, new therapies. IMAJ 2000;2:607-9.
4. Parkes M, Jewell D. Ulcerative Colitis and Crohn's disease: Molecular genetics and clinical implications. Expert Rev Mol Med 2001;2001:1-1800391-Xa. pdf
5. Calkins BM, Mendeloff AI. The epidemiology of idiopathic infl ammatory bowel disease. In: Kirsner JB, Shorter RG, editors Infl ammatory Bowel Disease. 4th ed. 1995; p. 31-68.
6. Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: Record linkage study World. J Gastroenterol 2010;16:431-8.
7. Giriş; M, Depboylu B, Doǧru-Abbasoǧlu S, Erbil Y, Olgaç; V, Aliş; H, et al. Effect of taurine on oxidative stress and apoptosis-related protein expression in trinitrobenzene sulphonic acid-induced colitis. Clin Exp Immunol 2008;152:102-10.
8. Razavi A, Khodadadi A, Eslami MB Eshraghi S. Therapeutic effect of sodium alginate in experimental chronic ulcerative colitis. Iran J Allergy Asthma Immunol 2008;7:13-8.
9. Patel MA, Patel PK, Patel MB. Effect of ethanol extract of Ficus begalensis on infl ammatory bowel disease. Indian J Pharmacol 2010;42:214-8.
10. Dhankhar S, Ruhil M, Balhar M. Aegle marmelos (Linn.) Correa: A potential source of Phytomedicine. J Med Plants Res 2011;5:1497-507.
11. Narushima S, Spitz DR. Evidence for oxidative stress in NSAID- induced colitis in IL-10 mice. Free Radic Biol Med 2003;34:1153-66.
12. Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental model of IBD. J Ethnopharmacol 2004;90:195-204.
13. Fedorak RN, Empey LR, MacArthur C, Jewell LD. Misoprostal provides a colonic mucosal protective effect during Acetic acid induced colitis in rats. Gastroenterology 1990;98:615-25.
14. Kakimoto K, Takai S, Murano M, Ishida K, Yoda Y, Inoue T, et al. Signifi cance of Chymase-Dependent Matrix Metalloproteinase-9 Activation on Indomethacin-Induced Small Intestinal Damages in Rats. J Pharmacol Exp Ther 2010;332:684-9.
15. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulphate sodium experimental murine colitis. Lab invest 1993;69:238-49.
16. Zeytunlu M, Korkut M, Akgün E, Firat O, Aynaci M, Iç;öz G, et al. The comparative effects of calcium channel blockers in an experimental colitis model in rats. Turk J Gastroenterol 2004;15:243-9.
17. Ayan f, Aydin S, Uzun H. Effects of clinoptilolite (Froximun Cama) on Trinitrobenzene sulfonic acid (TNBS)-induced colitis colitis model in the study as a new agent for Prevention and Treatment. Available from: Http://www.froximun. at/pdfs/13.pdf. [24.02.2012]
18. Dahel LK, Hill EG, Holman RT. The thiobarbituric acid reaction and autooxidation of polyunsaturated fatty acid methyl esters. Arch Biochem Biophys 1962;98:253-61.
19. Kakkar P, Das B, Viswanathan PN. Mechanisms of Gastric Mucosal Hemorrhagic Ulceration in Salmonella typhimurium-infected Rats: Protection by Several Drugs. Indian J BiochemBiophys 1984;21:130-2.
20. Norton S. Quantitative determination of mast cell fragmentation by compound 48/80. Br J Pharmacol Chemother 1954;9:494-7.
21. Rajan S, Gokila M, Jency P, Brindha P, Sujatha RK. Antioxidant and phytochemical properties of Aegle marmelos fruit pulp. Int J Curr Pharm Res 2011;3:65-70.
22. Harputluoglu MM, Demirel U, Yücel N, Karadaǧ N, Temel I, Firat S. The effects of Gingko biloba extract on acetic acid induced colitis in rats. Turk J Gastroenterol 2006;17:177-82.
23. Kurutas EB, Cetinkaya A, Bulbuloglu E, Kantarceken B. Effects of Antioxidant Therapy on Leukocyte Myeloperoxidase and Cu/Zn-Superoxide Dismutase and Plasma Malondialdehyde Levels in Experimental Colitis. Mediators Infl amm 2005;2005:390-4.
24. MacDonald TT, Muresh SH. Aetiology and pathogenesis of chronic infl ammatory bowel disease. Baillieres Clin Gastroenterol 1994;8:1-34.
25. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertson DA. Corticosteroid treatment reduces mast cell numbers in infl ammatory bowel disease. Dig Dis Sci 1990;35:1409-13
26. osek M, Bern C, Guerrant RL. The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003;81:197-204.
27. Boschi-Pinto C, Velebit L, Shibuya K. Estimating child mortality due to diarrhoea in developing countries. Bull World Health Organ 2008;86:710-7.
28. Sanchez J, Holmgren J. Cholera toxin structure, gene regulation and pathophysiological and immunological aspects. Cell Mol Life Sci 2008;65:1347-60.
29. Field M. Intestinal ion transport and the pathophysiology of diarrhea. J Clin Invest 2003;111:931-43.
30. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004;363:223-33.
31. Chandrasekhar MR, Krishna BV, Patil AB. Changing characteristics of Vibrio cholerae: Emergence of multidrug resistance and non-O1, non-O139 serogroups. Southeast Asian J Trop Med Public Health 2008;39:1092-7.
32. Barrett KE, Keely SJ. Chloride secretion by the intestinal epithelium: Molecular basis and regulatory aspects. Annu Rev Physiol 2000;62:535-72.
33. Thiagarajah JR, Verkman AS. CFTR pharmacology and its role in intestinal fl uid secretion. Curr Opin Pharmacol 2003;3:594-9.
34. Sheppard DN, Welsh MJ. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79 Suppl 1:S23-45.
35. Ma T, Thiagarajah JR, Yang H, Sonawane ND, Folli C, Galietta LJ, et al. Thiazolidinone CFTR inhibitor identifi ed by high-throughput screening blocks cholera toxin-induced intestinal fl uid secretion. J Clin Invest 2002;110:1651-8.
36. Verkman AS, Galietta LJ. Chloride channels as drug targets. Nat Rev Drug Discov 2009;8:153-71.
37. Muanprasat C, Sonawane ND, Salinas D, Taddei A, Galietta LJ, Verkman AS. Discovery of glycine hydrazide pore-occluding CFTR inhibitors: Mechanism, structure-activity analysis, and in vivo effi cacy. J Gen Physiol 2004;124:125-37.
38. Galietta LV, Jayaraman S, Verkman AS. Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol 2001;281:C1734-42.
39. Wongsamitkul N, Sirianant L, Muanprasat C, Chatsudthipong V. A plant-derived hydrolysable tannin inhibits CFTR chloride channel: A potential treatment of diarrhea. Pharm Res 2010;27:490-7.
40. Field M, Fromm D, al-Awqati Q, Greenough WB 3rd. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest 1972;51:796-804.
41. Pilewski JM, Frizzell RA. Role of CFTR in airway disease. Physiol Rev 1999;79 Suppl 1:S215-55.
42. Thiagarajah JR, Broadbent T, Hsieh E, Verkman AS. Prevention of toxininduced intestinal ion and fl uid secretion by a small-molecule CFTR inhibitor. Gastroenterology 2004;126:511-9.
43. Lohi H, Mäkelä S, Pulkkinen K, Höglund P, Karjalainen-Lindsberg ML, Puolakkainen P, et al. Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol 2002;283:G567-75.
44. Strohmeier GR, Reppert SM, Lencer WI, Madara JL. The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem 1995;270:2387-94.